Introduction
Transmission
Resource
July 10, 2020
News
July 7, 2020
Missed targets have resulted in 3.5 million more HIV infections and 820 000 more AIDS-related deaths since 2015 than if the world was on track to meet the 2020 targets.
Resource
July 1, 2020
The National Strategic Plan for HIV, TB and STIs (NSP) 2017-2022 Mid Term Review (MTR) was an in-depth analysis of the NSP implementation, with the aim to illustrate progress made towards reaching the NSP targets across the eight NSP goals.
Resource
June 10, 2020
What will happen to HIV and TB under COVID-19? Our editor-in-chief Mia Malan spoke to an excellent panel to answer this question.
News
November 28, 2019
A second case of HIV transmission from someone interrupting their HIV therapy as part of a cure study has been published.
Blog
November 27, 2019
This installment wraps up the ACCESS PrEP blog series and talks about combination prevention, particularly the effects of oral PrEP use on condom use.
Blog
November 27, 2019
The third blog in this ACCESS PrEP blog series addresses health providers’ experiences with oral PrEP services. It explores their knowledge of oral PrEP and concerns about increased risky behaviour. Health providers also expressed concern about the challenges clients faced when accessing oral PrEP and the barriers to uptake, adherence and continuation.
Blog
November 27, 2019
This narrative, the second in the ACCESS PrEP blog series, focuses on PrEP-related side effects. It highlights the determination of some clients to continue using oral PrEP despite the side effects they were experiencing.
Blog
November 27, 2019
This blog is the first in the ACCESS blog series and it gives an overview of the study findings. It explores the motivations that made clients decide to start, continue or stop using oral PrEP, as well as what made certain clients decide not to start taking oral PrEP at all.
Resource
September 2, 2019
The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to and determine whether revisions to the fifth edition of the Medical eligibility crit
